powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1992117014
Duo Xu
M.D.
Ophthalmology
Philadelphia,
PA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
5,338
Unique beneficiaries
—
Total services
37,601
Distinct HCPCS
23
Medicare payment
$5.5M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 810 Ophthalmology providers in PA — top quintile (cohort median 1,854).
PRESCRIBING · PART D · 2024
Total Rx claims
606
Beneficiaries
—
Total drug cost
$26K
Distinct drugs
12
Brand share
19.8%
Top prescribed drugs
Prednisolone Acetate
232 claims
Dorzolamide Hcl/Timolol Maleat
69 claims
Difluprednate
65 claims
Ketorolac Tromethamine
63 claims
Brimonidine Tartrate
40 claims
QUALITY · MIPS · 2024
Final MIPS score
98.8
Quality
97.9
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.00%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.